RecruitingNCT05995821

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies


Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Enrollment

1,250 participants

Start Date

Aug 25, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This research is being done to collect and store biological specimens (biospecimens) from people with cancer, regardless of tumor type, who are receiving treatments known or thought to have an effect on the immune system. The goal of this discovery and exploratory study is to: * Understand changes in the immune system associated with various cancer treatments, in order to better design new therapies or tests to predict how these treatments might work. * Identify risk factors for those who go on to develop side effects from immunotherapy. * Identify the molecular features associated with response and resistance to cancer therapies and immunotherapy using integrative genomic and immune repertoire characterization. * Capture and characterize systemic tumor burden by minimally invasive analyses of circulating tumor DNA. Participants may be asked to: * Donate samples of tumor, blood, lymph nodes, white blood cells, mouth cells (buccal smears) scraped from the inside of participant's cheek, urine, saliva, or other tissue samples. * Complete questionnaires about immunotherapy side effects at baseline and with follow-up appointments. * Undergo knee x-rays. * Allow the use of demographic and clinical information.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood and tissue samples from people with cancers of the throat, mouth, voice box, or nearby areas (upper aerodigestive tract). The samples will be used to study the immune system's role in these cancers and how immunotherapy drugs might work. **You may be eligible if...** - You have a confirmed or strongly suspected cancer of the upper aerodigestive tract (mouth, throat, voice box, nasal cavity, or related areas) - You may be receiving a treatment that affects the immune system - You are able to understand and sign an informed consent form **You may NOT be eligible if...** - You have a very low red blood cell count (hemoglobin below 8.5 g/dL) that makes blood draws unsafe - You have a serious bleeding disorder that makes biopsies (tissue samples) unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCollection of biological specimens

Collection of tumor, blood, lymph nodes, white blood cells, mouth cells (buccal smears) scraped from the inside of your cheek, urine, saliva, or other tissue samples.


Locations(1)

Johns Hopkins University

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05995821


Related Trials